We are live on ! Find out more
FBLG icon

FibroBiologics

52 hedge funds and large institutions have $3.28M invested in FibroBiologics in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.14% less ownership

Funds ownership: 0.78%0.64% (-0.14%)

9% less funds holding

Funds holding: 5752 (-5)

12% less capital invested

Capital invested by funds: $3.75M → $3.28M (-$467K)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

55% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 20

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
52
Holders Change
-5
Holders Change %
-8.77%
% of All Funds
0.68%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
8
Increased
9
Reduced
20
Closed
13
Calls
Puts
Net Calls
Net Calls Change

FBLG Hedge Fund Activity: Q3 2025 in Review

52 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in FibroBiologics (FBLG) for Q3 2025, worth a combined $3.28M — down 12% from $3.75M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of FBLG and 8 opened new positions — a net loss of 5 holders — while 20 trimmed existing stakes and 9 added.

The largest buyer was Landscape Capital Management, opening a new position worth an estimated $210K. The largest seller was Yorkville Advisors Global, cutting an estimated $200K.

  • 52 institutional investors held FibroBiologics (FBLG) as of Q3 2025, down from 57 in Q2 2025.
  • Funds reported $3.28M of FibroBiologics stock for Q3 2025, down 12% quarter-over-quarter.
  • 8 funds opened new FibroBiologics positions in Q3 2025 and 13 closed out, a net change of -5 holders.
  • The largest FibroBiologics buyer in Q3 2025 was Landscape Capital Management, an estimated $210K added.
  • The largest FibroBiologics seller in Q3 2025 was Yorkville Advisors Global, an estimated $200K sold.

Based on aggregated 13F filings for Q3 2025.